Sugar alcohol-based polymeric gene carriers: Synthesis, properties and gene therapy applications. (1st October 2019)

• Record Type: Journal Article
• Authors: Hong, Seo Jin; Ahn, Min Hye; Sangshetti, Jaiprakash; Arote, Rohidas B.
• Is Part Of: Acta biomaterialia. Volume 97(2019)
• Page Start: 105
• Page End: 115
• Publication Date: 2019-10-01
• Subjects: Gene delivery -- Sugar alcohol -- Nanocarriers -- Nanomedicine -- Transfection efficiency -- Cytotoxicity -- Sugar alcohol-based polymers; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1016/j.actbio.2019.07.029
• Languages: English
• ISSNs: 1742-7061

Abstract

Graphical abstract: Abstract: Advances in the field of nanomedicine have led to the development of various gene carriers with desirable cellular responses. However, unfavorable stability and physicochemical properties have hindered their applications in vivo . Therefore, multifunctional, smart nanocarriers with unique properties to overcome such drawbacks are needed. Among them, sugar alcohol-based nanoparticle with abundant surface chemistry, numerous hydroxyl groups, acceptable biocompatibility and biodegradable property are considered as the recent additions to the growing list of non-viral vectors. In this review, we present some of the major advances in our laboratory in developing sugar-based polymers as non-viral gene delivery vectors to treat various diseases. We also discuss some of the open questions in this field. Statement of Significance: Recently, the development of sugar alcohol-based polymers conjugated with polyethylenimine (PEI) has attracted tremendous interest as gene delivery vectors. First, the natural backbone of polymers with their numerous hydroxyl groups display a wide range of hyperosmotic properties and can thereby enhance the cellular uptake of genetic materials via receptor-mediated endocytosis. Second, conjugation of a PEI backbone with sugar alcohols via Michael addition contributes to buffering capacity and thereby the proton sponge effect. Last, sugar alcohol based gene delivery systems improves therapeutic efficacy both in vitro and in vivo .